Expertise in
18
conditions

Dr. Michael J. Glantz

Neurology
Berkshire Internists Of BMC
777 North St, 
Pittsfield, MA 
Expertise in
18
conditions
Berkshire Internists Of BMC
777 North St, 
Pittsfield, MA 

Overview

Michael Glantz is a Neurologist practicing medicine in Pittsfield, Massachusetts.

Dr. Glantz is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Glioblastoma, Astrocytoma, Glioma, Brain Tumor, and Thrombectomy.

He is actively involved in clinical research, co-authoring 72 peer reviewed articles and participating in 7 clinical trials.

Specialties

Neurology

Licenses

Neurological Surgery in PA

Hospital Affiliations

North Adams Regional Hospital Corporation
Berkshire Medical Center
Fairview Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Gateway Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • OTHER MEDICARE PART D
Geisinger
  • HMO
  • POS
  • PPO
Health Partners Plans
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
PA Health and Wellness
  • HMO
  • MANAGED MEDICAID PLAN
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 7 Less Insurance Carriers -

Locations

Berkshire Internists of BMC
777 North St, Pittsfield, MA 01201

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Multicenter, Open-Label Study With a Randomized Control Arm of the Efficacy, Safety, and Pharmacokinetics of Intravenously Infused Berubicin in Adult Patients With Recurrent Glioblastoma Multiforme After Failure of Standard First Line Therapy
A Multicenter, Open-Label Study With a Randomized Control Arm of the Efficacy, Safety, and Pharmacokinetics of Intravenously Infused Berubicin in Adult Patients With Recurrent Glioblastoma Multiforme After Failure of Standard First Line Therapy
Enrollment Status: Active_not_recruiting
Publish Date: April 15, 2026
Intervention Type: Drug
Study Drugs: Berubicin, Lomustine
Study Phase: Phase 2
An Open-label Phase II Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Tirabrutinib in Patients With Primary Central Nervous System Lymphoma (PCNSL)
An Open-label Phase II Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Tirabrutinib in Patients With Primary Central Nervous System Lymphoma (PCNSL)
Enrollment Status: Active_not_recruiting
Publish Date: March 30, 2026
Intervention Type: Drug
Study Phase: Phase 2
A Phase I/II Study of the Combination of Indoximod and Temozolomide for Adult Patients With Temozolomide-Refractory Primary Malignant Brain Tumors
A Phase I/II Study of the Combination of Indoximod and Temozolomide for Adult Patients With Temozolomide-Refractory Primary Malignant Brain Tumors
Enrollment Status: Completed
Publish Date: March 27, 2024
Intervention Type: Drug, Radiation
Study Phase: Phase 1/Phase 2
A Biospecimen Collection Study to Evaluate the Pharmacokinetic, Pharmacodynamic, and Resistance Profile to Trametinib and Dabrafenib in BRAF-V600E Mutated Recurrent Gliomas
A Biospecimen Collection Study to Evaluate the Pharmacokinetic, Pharmacodynamic, and Resistance Profile to Trametinib and Dabrafenib in BRAF-V600E Mutated Recurrent Gliomas
Enrollment Status: Terminated
Publish Date: October 06, 2023
Intervention Type: Procedure
A Phase 3, Randomized, Controlled, Double-Arm, Open-Label, Multi-center Study of VB-111 Combined With Bevacizumab vs. Bevacizumab Monotherapy in Patients With Recurrent Glioblastoma
A Phase 3, Randomized, Controlled, Double-Arm, Open-Label, Multi-center Study of VB-111 Combined With Bevacizumab vs. Bevacizumab Monotherapy in Patients With Recurrent Glioblastoma
Enrollment Status: Completed
Publish Date: October 23, 2018
Intervention Type: Drug
Study Phase: Phase 3
View 4 Less Clinical Trials

72 Total Publications

Predicting late radiation-associated neurocognitive and endocrine toxicity in patients with brain tumors.
Predicting late radiation-associated neurocognitive and endocrine toxicity in patients with brain tumors.
Journal: Journal of neuro-oncology
Published: April 10, 2026
Similar Doctors
Expertise in
46
conditions
Expertise in
46
conditions
Referral may be required

Albany Medical College

215 Washington Avenue Ext, 
Albany, NY 
 (34.8 miles away)
518-452-0914
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Eric Molho is a Neurologist practicing medicine in Albany, New York. Dr. Molho is highly rated in 46 conditions, according to our data. His clinical expertise encompasses Movement Disorders, Parkinson's Disease, Drug Induced Dyskinesia, Focal Dystonia, and Deep Brain Stimulation.

Expertise in
11
conditions
Expertise in
11
conditions
Referral may be required

Albany Stratton Veterans Affairs Medical Center

113 Holland Ave, 
Albany, NY 
 (29.8 miles away)
518-626-6373
Languages Spoken:
English
See accepted insurances

Arnulf Koeppen is a Neurologist practicing medicine in Albany, New York. Dr. Koeppen is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Friedreich Ataxia, Cerebelloolivary Atrophy, Spinocerebellar Ataxia, and Hereditary Ataxia.

Expertise in
39
conditions
Expertise in
39
conditions
Referral may be required

Albany Medical Center

43 New Scotland Ave., Floor 1 Suite 70, 
Albany, NY 
 (29.9 miles away)
518-262-5226
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Kathrin Lafaver is a Neurologist practicing medicine in Albany, New York. Dr. Lafaver is highly rated in 39 conditions, according to our data. Her clinical expertise encompasses Movement Disorders, Conversion Disorder, Parkinson's Disease, and Drug Induced Dyskinesia. Dr. Lafaver is currently accepting new patients.

Frequently Asked Questions about Dr. Michael J. Glantz

How do I make an appointment with Dr. Michael J. Glantz?

You can book an appointment with Dr. Michael J. Glantz by calling their office at 413-395-7694. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Michael J. Glantz a top-rated expert for Glioblastoma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Michael J. Glantz is classified as an Elite expert for Glioblastoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Michael J. Glantz specialize in?

While Dr. Michael J. Glantz is a Neurology, they have specific expertise in Glioblastoma, Astrocytoma, and Glioma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Neurology.

Does Dr. Michael J. Glantz participate in research or clinical trials?

Yes. Dr. Michael J. Glantz has published 72 articles and abstracts on conditions like Glioblastoma. You can view a list of Dr. Michael J. Glantz's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Michael J. Glantz accept my insurance?

Dr. Michael J. Glantz accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 413-395-7694 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Glantz's expertise for a condition
ConditionClose
View All 9 Distinguished Conditions
View All 16 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile